You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
A phylogenetic analysis of green-blooded lizards find the trait likely arose more than once, Reuters reports.
The HPOs will receive $13.8 million to enroll people interested in the All of Us program, gather participant health information, and help retain participants.
Two researchers devised a protocol to sequence DNA from ancient samples and tested it on 100-year-old museum specimens.
The organizations in the consortium will identify, characterize, and catalog human biological molecules affected by physical activity in volunteer biosamples.
LSU Health New Orleans and OmniSeq will collaborate to offer next-generation sequencing-based tumor profiling services to the institution's oncologists.
Researchers used thousands of conserved sequences for more than 100 songbird species to reconstruct their diversification and historical expansion route.
The partners will provide comprehensive clinical genomic testing for tumor profiling and inherited genetic disease at LSU Health New Orleans' Precision Medicine Program.
Aiming to improve upon existing bone-growth agents, a team from Louisiana State University is developing a light-activated nanoparticle for the targeted delivery of microRNA mimics involved in bone and blood vessel growth.
US patents awarded to Gen-Probe, Life Genetics, Louisiana State University, Agilent, and Roche/454 Life Sciences.
Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.
A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.
In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.
According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.